Compugen (CGEN) Reports Q1 Loss, Misses Revenue Estimates

Compugen (CGEN) came out with a quarterly loss of $0.08 per share versus the Zacks Consensus Estimate of a loss of $0.10. This compares to loss of $0.11 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 20%. A quarter ago, it was expected that this drug developer would post earnings of $0.10 per share when it actually produced earnings of $0.11, delivering a surprise of 10%. Investors should be mindful of the fact that the outl ...